Clinical Research Directory

Study That Will Evaluate the Brazilian Population With COPD.

Sponsor: AstraZeneca

Summary

Observational, prospective, multicenter cohort study with consecutive inclusion of COPD patients. Eligible patients will be those with severe and very severe COPD according to the GOLD 2024 (Global Initiative for Chronic Obstructive Lung Disease) guidelines being followed at participating hospitals. The severity of COPD is related to the exacerbation rate, which in turn is related to the progression of the disease and the occurrence of complications and death. There is no national data on this subgroup.

Official title: Prospective Multicentric Cohort Study of Severe and Very Severe COPD Patients in Brazil.

Key Details

Conditions

Locations (10)